Cerdelga (eliglustat) is a small molecule pharmaceutical. Eliglustat was first approved as Cerdelga on 2014-08-19. It is used to treat gaucher disease in the USA. It has been approved in Europe to treat gaucher disease. Cerdelga's patents are valid until 2038-12-13 (FDA).
|Drug Class||Enzyme inhibitors: glucosyltransferase inhibitors|